Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
Nicola Capasso, Eleonora Virgilio, Antonio Covelli, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 25

Showing 25 citing articles:

Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis
Maria A. Rocca, Paolo Preziosa, Frederik Barkhof, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 100978-100978
Open Access | Times Cited: 6
Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis
Riccardo Nistri, Antonio Ianniello, Valeria Pozzilli, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1120-1120
Open Access | Times Cited: 5
Therapeutic Advances in Pediatric Multiple Sclerosis
R. J. Walsh, Tanuja Chitnis
Children (2025) Vol. 12, Iss. 3, pp. 259-259
Open Access
Distinct clinical, imaging, and cerebrospinal fluid profiles in people with late-onset multiple sclerosis
Lukas Steinegger, Veronika Kana, Nathalie Nierobisch, et al.
Multiple Sclerosis and Related Disorders (2025), pp. 106399-106399
Open Access
Experimental autoimmune encephalomyelitis pathogenesis alters along animal age: impact of S100B expression
Ana Rita Ribeiro, Raquel Pereira, Catarina Barros, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
Association of Higher Mediterranean Diet Adherence With Lower Prevalence of Disability and Symptom Severity, Depression, Anxiety, Stress, Sleep Quality, Cognitive Impairment, and Physical Inactivity in Older Adults With Multiple Sclerosis
Christina Tryfonos, Eleni Pavlidou, Theofanis Vorvolakos, et al.
Journal of Geriatric Psychiatry and Neurology (2023) Vol. 37, Iss. 4, pp. 318-331
Closed Access | Times Cited: 9
Associations between Mediterranean Diet Adherence, Quality of Life, and Mental Health in Patients with Multiple Sclerosis: A Cross-Sectional Study
Antonios Dakanalis, Christina Tryfonos, Eleni Pavlidou, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 3
Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
Lorena Lorefice, Giuseppe Fenu, Marzia Fronza, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Biological variation estimates for serum neurofilament light chain in healthy subjects
Anna Carobene, Kenneth Maiese, Charbel Abou‐Diwan, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117608-117608
Closed Access | Times Cited: 6
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey
Hayrettin Tumani, Patricia K. Coyle, Claudia Cárcamo, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 4
Aging-dependent Change in Th17 and Cytokine Response in Multiple Sclerosis
Wen Zhu, Shankar Revu, Chenyi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database
Xiping Yang, Yan Yan, Suyao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Safety of high efficacy therapies in older people with Multiple Sclerosis: a real-world evidence study
Berenice Silva, Federico Casales, Claudia Burbano Donoso, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 90, pp. 105830-105830
Closed Access | Times Cited: 1
Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis
Nora Hijal, Malak Fouani, Bassel Awada
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Ocrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosis
Fabiënne van Puijfelik, Katelijn M. Blok, Romy A. M. Klein Kranenbarg, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients
Serkan Özakbaş, Ergi Kaya, Taha Aslan, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 90, pp. 105810-105810
Closed Access
Comprehensive Analysis of Multiple Sclerosis Hospitalization Trends in Spain (1998-2022)
Lucía Cayuela, Cristina García‐Muñoz, Aurelio Cayuela
Multiple Sclerosis and Related Disorders (2024) Vol. 91, pp. 105887-105887
Closed Access
Neurovirology and Brain Health—A Microglial Perspective
Anindya Kishor Biswas, Jayasri Das Sarma
Healthy ageing and longevity (2024), pp. 119-142
Closed Access
Multiple sclerosis and cancer: Navigating a dual diagnosis
Cassie Nesbitt, Anneke van der Walt, Helmut Butzkueven, et al.
Multiple Sclerosis Journal (2024)
Closed Access
Cerebrospinal fluid neurofilament light chain levels in children with acquired demyelinating syndrome
Wenlin Wu, Chi Hou, Wenxiao Wu, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access
Cognitive Function in Frail Older Adults With Multiple Sclerosis: An Exploratory Study Using Secondary Data Analysis
Émerson Sebastião, Vitor Antonio Assis Alves Siqueira, Jemimah Bakare, et al.
International Journal of MS Care (2024) Vol. 26, Iss. Q4, pp. 315-320
Open Access
Review of evidence linking exposure to environmental stressors and associated alterations in the dynamics of immunosenescence (ISC) with the global increase in multiple sclerosis (MS)
C. Bolton
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Age and sex as key determinants of multiple sclerosis incidence in Spain: a comprehensive analysis using the global burden of disease database (1990–2019)
Lucía Cayuela, Cristina García‐Muñoz, Aurelio Cayuela
Neurological Sciences (2024)
Closed Access
Clinical, immunological and neuroimaging spectrum of CNS lupus: can we reliably differentiate it from MS?
Anna Wójcicka-Frankiewicz, Mikołaj A. Pawlak, Alicja Kalinowska-Łyszczarz
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 6, pp. 557-568
Closed Access
From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
Muhammad Faraz Raghib, Evanthia Bernitsas
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3069-3069
Open Access | Times Cited: 1
Page 1

Scroll to top